BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$274M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$34.1M
2
+$31.1M
3
+$21M
4
AVDL
Avadel Pharmaceuticals
AVDL
+$20.1M
5
EBS icon
Emergent Biosolutions
EBS
+$18.5M

Top Sells

1
+$29.1M
2
+$23.4M
3
+$22.5M
4
NVDQ
Novadaq Technologies Inc.
NVDQ
+$16.6M
5
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$14.9M

Sector Composition

1 Healthcare 79.95%
2 Technology 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$14M 1.36%
+43,097
27
$13.8M 1.34%
766,010
+41,010
28
$13.4M 1.3%
712,495
+275,000
29
$13.1M 1.27%
23,558
-2,571
30
$12.5M 1.21%
1,005,221
+805,221
31
$12.4M 1.2%
+667,435
32
$12M 1.16%
3,058,644
+889,113
33
$11.2M 1.08%
411,100
-550,000
34
$11M 1.07%
955,147
-209,400
35
$10.4M 1.01%
+175,000
36
$10.3M 1%
275,000
+45,700
37
$9.09M 0.88%
774,881
-99,119
38
$8.88M 0.86%
380,188
+58,800
39
$8.66M 0.84%
1,083,087
-72,236
40
$8.47M 0.82%
150,000
41
$8.05M 0.78%
2,300,000
+1,500,000
42
$6.96M 0.67%
1,050,000
+16,332
43
$6.5M 0.63%
+25,525
44
$6.23M 0.6%
+881,605
45
$5.86M 0.57%
440,450
-103,579
46
$5.51M 0.53%
+31
47
$5.34M 0.52%
+100,000
48
$5.33M 0.52%
+641,700
49
$5.25M 0.51%
+254,068
50
– –
0
1
2
3 4